Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014325

SVP Chief Financial Officer sold 2,853 shares at an average $25.18 ($71,844)

  • SVP Chief Financial Officer acquired 27,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Vairavan Latha · SVP Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-27 Grant or award : show line 1 in the form 10b5-1 +27,000 90,607 D
2026-03-02 Sale : show line 2 in the form 10b5-1 −2,772 $25.16 $69,745 87,835 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −81 $25.91 $2,099 87,754 D
Open-market sales · 2,853 sh · avg $25.18 · $71,844

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-27 Grant or award : show line 4 in the form 10b5-1 Stock Option (right to buy) +70,000 70,000 D
Loading xslF345X05/wk-form4_1772588527.xml…